Literature DB >> 12692291

Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha.

Michael Frese1,2, Kerstin Barth2, Artur Kaul1, Volker Lohmann1, Verena Schwärzle2, Ralf Bartenschlager1.   

Abstract

It was demonstrated using self-replicating hepatitis C virus (HCV) RNAs that both types of interferons (IFNs) (in particular IFN-alpha and IFN-gamma) are potent inhibitors of HCV replication in Huh-7 cells. Because IFN-gamma and tumour necrosis factor (TNF)-alpha trigger a partially overlapping set of antiviral defence mechanisms, it is tempting to speculate that TNF-alpha also inhibits HCV replication. However, this study shows that TNF-alpha does not affect HCV protein and RNA synthesis, nor does it synergistically enhance the inhibitory effect of IFN-gamma. Taken together, these results demonstrate that HCV replication in Huh-7 cells is highly resistant to TNF-alpha. It is, therefore, unlikely that the increased production of TNF-alpha, which is seen in many hepatitis C patients, contributes to HCV clearance by inducing antiviral defence mechanisms in infected hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692291     DOI: 10.1099/vir.0.18997-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  37 in total

1.  Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.

Authors:  Filiz Akyüz; Nuray Polat; Sabahattin Kaymakoglu; Nevzat Aksoy; Kadir Demir; Fatih Beşişik; Selim Badur; Yilmaz Cakaloglu; Atilla Okten
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Blockade of virus infection by human CD4+ T cells via a cytokine relay network.

Authors:  Ann M Davis; Kristan A Hagan; Loderick A Matthews; Gagan Bajwa; Michelle A Gill; Michael Gale; J David Farrar
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

3.  Targeting ribosome assembly on the HCV RNA using a small RNA molecule.

Authors:  Prasanna Bhat; Sivakumar Vadivel Gnanasundram; Prashant Mani; Partho Sarothi Ray; Debi P Sarkar; Saumitra Das
Journal:  RNA Biol       Date:  2012-08-01       Impact factor: 4.652

4.  Knockdown of USP18 increases α 2a interferon signaling and induction of interferon-stimulating genes but does not increase antiviral activity in Huh7 cells.

Authors:  E J Murray; Frances Burden; Nigel Horscroft; Caroline Smith-Burchnell; Mike Westby
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

5.  Regulation of hepatitis C virus replication by interferon regulatory factor 1.

Authors:  Nobuhiko Kanazawa; Masayuki Kurosaki; Naoya Sakamoto; Nobuyuki Enomoto; Yasuhiro Itsui; Tsuyoshi Yamashiro; Yoko Tanabe; Shinya Maekawa; Mina Nakagawa; Cheng-Hsin Chen; Sei Kakinuma; Shigeru Oshima; Tetsuya Nakamura; Takanobu Kato; Takaji Wakita; Mamoru Watanabe
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA.

Authors:  Tanmoy Mondal; Upasana Ray; Asit Kumar Manna; Romi Gupta; Siddhartha Roy; Saumitra Das
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

7.  Psammaplin A inhibits hepatitis C virus NS3 helicase.

Authors:  Kazi Abdus Salam; Atsushi Furuta; Naohiro Noda; Satoshi Tsuneda; Yuji Sekiguchi; Atsuya Yamashita; Kohji Moriishi; Masamichi Nakakoshi; Masayoshi Tsubuki; Hidenori Tani; Junichi Tanaka; Nobuyoshi Akimitsu
Journal:  J Nat Med       Date:  2013-01-29       Impact factor: 2.343

8.  Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy.

Authors:  Upasana Ray; Chaitrali L Roy; Anuj Kumar; Prashant Mani; Agnel P Joseph; G Sudha; Debi P Sarkar; N Srinivasan; Saumitra Das
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

9.  Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.

Authors:  Wei Yang; Chao Qiu; Nabanita Biswas; Jing Jin; Simon C Watkins; Ronald C Montelaro; Carolyn B Coyne; Tianyi Wang
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

10.  Novel chimeric genotype 1b/2a hepatitis C virus suitable for high-throughput screening.

Authors:  Yingjia Zhang; Peter Weady; Rohit Duggal; Weidong Hao
Journal:  Antimicrob Agents Chemother       Date:  2007-11-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.